Conditions: Hepatocellular Carcinoma
Keywords: CT perfusion Hepatocellular Carcinoma Xenetix Contrast agent
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 96
Healthy volunteers: no

Brief summary:
The purpose of this study is to prospectively determine the diagnostic value of Xenetix-CT perfusion for the discrimination between well-differentiated hepatocellular carcinomas (HCC) and poorly/moderately differentiated HCC, in histo-pathologically proven HCC, and with the aim to cover the entire liver.

Detailed description:

Arms:
arm 1: arm with CT perfusion

Interventions: intervention 1: Xenetix-CT perfusion imaging
Intervention descriptions: intervention 1: Injection of 50 ml of Xenetix

Protocol document: